# J.Jill, Inc.: financial statements, quarterly

JILL · NYSE · CIK 1687932 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 30

Pages: [Overview](/companies/jill.md) · [Financials](/companies/jill/financials.md) · [Filings](/companies/jill/filings.md) · [Insiders](/companies/jill/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/jill/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [151](/filings/0000950170-24-135426.md) | [150 d](/filings/0001193125-26-134566.md) | [162](/filings/0000950170-25-084826.md) | [155](/filings/0001193125-25-194952.md) | [151](/filings/0001193125-25-314318.md) | [143 d](/filings/0001193125-26-134566.md) | [154](/filings/0001193125-26-265857.md) | [154](/filings/0001193125-26-386569.md) | [151](/filings/0001193125-25-314318.md) | [138 d](/filings/0001193125-26-134566.md) | [144](/filings/0001193125-26-265857.md) | [155](/filings/0001193125-26-386569.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [109](/filings/0000950170-24-135426.md) | [101 d](/filings/0001193125-26-134566.md) | [118](/filings/0000950170-25-084826.md) | [109](/filings/0001193125-25-194952.md) | [108](/filings/0001193125-25-314318.md) | [94.8 d](/filings/0001193125-26-134566.md) | [110](/filings/0001193125-26-265857.md) | [105](/filings/0001193125-26-386569.md) | [107](/filings/0001193125-25-314318.md) | [87.3 d](/filings/0001193125-26-134566.md) | [98.7](/filings/0001193125-26-265857.md) | [119](/filings/0001193125-26-386569.md) |
| Selling, general and administrative | $m | [86.5](/filings/0000950170-24-135426.md) | [90.8 d](/filings/0001193125-26-134566.md) | [89.1](/filings/0000950170-25-084826.md) | [86.3](/filings/0001193125-25-194952.md) | [88.6](/filings/0001193125-25-314318.md) | [89.3 d](/filings/0001193125-26-134566.md) | [91.1](/filings/0001193125-26-265857.md) | [88.6](/filings/0001193125-26-386569.md) | [91.8](/filings/0001193125-25-314318.md) | [87.0 d](/filings/0001193125-26-134566.md) | [89.7](/filings/0001193125-26-265857.md) | [94.6](/filings/0001193125-26-386569.md) |
| Operating income | $m | [22.1](/filings/0000950170-24-135426.md) | [10.5 d](/filings/0001193125-26-134566.md) | [28.4](/filings/0000950170-25-084826.md) | [23.0](/filings/0001193125-25-194952.md) | [19.2](/filings/0001193125-25-314318.md) | [5.1 d](/filings/0001193125-26-134566.md) | [19.1](/filings/0001193125-26-265857.md) | [16.8](/filings/0001193125-26-386569.md) | [14.9](/filings/0001193125-25-314318.md) | [(0.2) d](/filings/0001193125-26-134566.md) | [8.8](/filings/0001193125-26-265857.md) | [24.3](/filings/0001193125-26-386569.md) |
| Interest expense | $m | [6.5](/filings/0000950170-24-135426.md) | [6.9 d](/filings/0001193125-26-134566.md) | [6.4](/filings/0000950170-25-084826.md) | [3.7](/filings/0001193125-25-194952.md) | [2.8](/filings/0001193125-25-314318.md) | [2.7 d](/filings/0001193125-26-134566.md) | [2.8](/filings/0001193125-26-265857.md) | [2.7](/filings/0001193125-26-386569.md) | [2.7](/filings/0001193125-25-314318.md) | [2.2 d](/filings/0001193125-26-134566.md) | [1.9](/filings/0001193125-26-265857.md) | [1.9](/filings/0001193125-26-386569.md) |
| Income tax | $m | [4.7](/filings/0000950170-24-135426.md) | [(0.2) d](/filings/0001193125-26-134566.md) | [6.2](/filings/0000950170-25-084826.md) | [3.1](/filings/0001193125-25-194952.md) | [4.5](/filings/0001193125-25-314318.md) | [0.7 d](/filings/0001193125-26-134566.md) | [5.0](/filings/0001193125-26-265857.md) | [4.0](/filings/0001193125-26-386569.md) | [3.6](/filings/0001193125-25-314318.md) | [(1.4) d](/filings/0001193125-26-134566.md) | [2.5](/filings/0001193125-26-265857.md) | [6.7](/filings/0001193125-26-386569.md) |
| Net income | $m | [11.6](/filings/0000950170-24-135426.md) | [4.8 d](/filings/0001193125-26-134566.md) | [16.7](/filings/0001193125-25-314318.md) | [8.2](/filings/0001193125-25-314318.md) | [12.3](/filings/0001193125-25-314318.md) | [2.2 d](/filings/0001193125-26-134566.md) | [11.7](/filings/0001193125-26-386569.md) | [10.5](/filings/0001193125-26-386569.md) | [9.2](/filings/0001193125-25-314318.md) | [(3.5) d](/filings/0001193125-26-134566.md) | [4.7](/filings/0001193125-26-386569.md) | [16.8](/filings/0001193125-26-386569.md) |
| Diluted EPS | $ per share | [0.80](/filings/0000950170-24-135426.md) | not reported | [1.16](/filings/0000950170-25-084826.md) | [0.54](/filings/0001193125-25-194952.md) | [0.80](/filings/0001193125-25-314318.md) | not reported | [0.76](/filings/0001193125-26-265857.md) | [0.69](/filings/0001193125-26-386569.md) | [0.60](/filings/0001193125-25-314318.md) | not reported | [0.31](/filings/0001193125-26-265857.md) | [1.11](/filings/0001193125-26-386569.md) |
| Basic EPS | $ per share | [0.82](/filings/0000950170-24-135426.md) | not reported | [1.17](/filings/0000950170-25-084826.md) | [0.55](/filings/0001193125-25-194952.md) | [0.81](/filings/0001193125-25-314318.md) | not reported | [0.76](/filings/0001193125-26-265857.md) | [0.69](/filings/0001193125-26-386569.md) | [0.61](/filings/0001193125-25-314318.md) | not reported | [0.32](/filings/0001193125-26-265857.md) | [1.12](/filings/0001193125-26-386569.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-28) | FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [64.1](/filings/0000950170-23-068143.md) | [62.2](/filings/0001193125-26-134566.md) | [77.1](/filings/0000950170-25-084826.md) | [28.5](/filings/0001193125-25-194952.md) | [38.8](/filings/0001193125-25-314318.md) | [35.4](/filings/0001193125-26-134566.md) | [31.2](/filings/0001193125-26-265857.md) | [45.5](/filings/0001193125-26-386569.md) | [58.0](/filings/0001193125-25-314318.md) | [41.0](/filings/0001193125-26-386569.md) | [36.3](/filings/0001193125-26-265857.md) | [76.9](/filings/0001193125-26-386569.md) |
| Current assets | $m | [144](/filings/0000950170-23-068143.md) | [138](/filings/0000950170-25-048494.md) | [159](/filings/0000950170-24-070236.md) | [106](/filings/0000950170-24-103118.md) | [126](/filings/0000950170-24-135426.md) | [122](/filings/0001193125-26-134566.md) | [122](/filings/0000950170-25-084826.md) | [130](/filings/0001193125-25-194952.md) | [150](/filings/0001193125-25-314318.md) | [141](/filings/0001193125-26-386569.md) | [134](/filings/0001193125-26-265857.md) | [156](/filings/0001193125-26-386569.md) |
| Total assets | $m | [438](/filings/0000950170-23-068143.md) | [428](/filings/0000950170-25-048494.md) | [444](/filings/0000950170-24-070236.md) | [391](/filings/0000950170-24-103118.md) | [418](/filings/0000950170-24-135426.md) | [418](/filings/0001193125-26-134566.md) | [433](/filings/0000950170-25-084826.md) | [437](/filings/0001193125-25-194952.md) | [458](/filings/0001193125-25-314318.md) | [450](/filings/0001193125-26-386569.md) | [437](/filings/0001193125-26-265857.md) | [458](/filings/0001193125-26-386569.md) |
| Current liabilities | $m | [136](/filings/0000950170-23-068143.md) | [155](/filings/0000950170-25-048494.md) | [159](/filings/0000950170-24-070236.md) | [119](/filings/0000950170-24-103118.md) | [130](/filings/0000950170-24-135426.md) | [127](/filings/0001193125-26-134566.md) | [124](/filings/0000950170-25-084826.md) | [117](/filings/0001193125-25-194952.md) | [131](/filings/0001193125-25-314318.md) | [131](/filings/0001193125-26-386569.md) | [118](/filings/0001193125-26-265857.md) | [120](/filings/0001193125-26-386569.md) |
| Total liabilities | $m | [406](/filings/0000950170-23-068143.md) | [391](/filings/0000950170-25-048494.md) | [391](/filings/0000950170-24-070236.md) | [300](/filings/0000950170-24-103118.md) | [315](/filings/0000950170-24-135426.md) | [312](/filings/0001193125-26-134566.md) | [321](/filings/0000950170-25-084826.md) | [315](/filings/0001193125-25-194952.md) | [329](/filings/0001193125-25-314318.md) | [329](/filings/0001193125-26-386569.md) | [313](/filings/0001193125-26-265857.md) | [318](/filings/0001193125-26-386569.md) |
| Long-term debt | $m | [149](/filings/0000950170-23-068143.md) | [121](/filings/0000950170-25-048494.md) | [119](/filings/0000950170-24-070236.md) | [68.8](/filings/0000950170-24-103118.md) | [69.1](/filings/0000950170-24-135426.md) | not reported | not reported | not reported | not reported | [71.4](/filings/0001193125-26-386569.md) | [71.3](/filings/0001193125-26-265857.md) | [71.2](/filings/0001193125-26-386569.md) |
| Current portion of debt | $m | [8.8](/filings/0000950170-23-068143.md) | [35.4](/filings/0000950170-25-048494.md) | [35.4](/filings/0000950170-24-070236.md) | [4.4](/filings/0000950170-24-103118.md) | [2.2](/filings/0000950170-24-135426.md) | not reported | not reported | not reported | not reported | [1.9](/filings/0001193125-26-386569.md) | [1.6](/filings/0001193125-26-265857.md) | [1.3](/filings/0001193125-26-386569.md) |
| Shareholders' equity | $m | [31.7](/filings/0000950170-24-135426.md) | [37.2](/filings/0001193125-26-134566.md) | [53.1](/filings/0001193125-25-314318.md) | [90.4](/filings/0001193125-25-314318.md) | [103](/filings/0001193125-25-314318.md) | [106](/filings/0001193125-26-386569.md) | [112](/filings/0001193125-26-386569.md) | [122](/filings/0001193125-26-386569.md) | [129](/filings/0001193125-25-314318.md) | [121](/filings/0001193125-26-386569.md) | [124](/filings/0001193125-26-386569.md) | [140](/filings/0001193125-26-386569.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [21.1 d](/filings/0000950170-24-135426.md) | [6.6 d](/filings/0001193125-26-134566.md) | [21.5](/filings/0000950170-25-084826.md) | [16.4 d](/filings/0001193125-25-194952.md) | [19.1 d](/filings/0001193125-25-314318.md) | [8.1 d](/filings/0001193125-26-134566.md) | [5.3](/filings/0001193125-26-265857.md) | [19.4 d](/filings/0001193125-26-386569.md) | [19.1 d](/filings/0001193125-25-314318.md) | [(1.6) d](/filings/0001193125-26-134566.md) | [1.7](/filings/0001193125-26-265857.md) | [46.3 d](/filings/0001193125-26-386569.md) |
| Capital expenditure | $m | [2.3 d](/filings/0000950170-24-135426.md) | [4.9 d](/filings/0001193125-26-134566.md) | [1.7](/filings/0000950170-25-084826.md) | [1.4 d](/filings/0001193125-25-194952.md) | [4.4 d](/filings/0001193125-25-314318.md) | [6.7 d](/filings/0001193125-26-134566.md) | [2.2](/filings/0001193125-26-265857.md) | [2.3 d](/filings/0001193125-26-386569.md) | [3.0 d](/filings/0001193125-25-314318.md) | [9.4 d](/filings/0001193125-26-134566.md) | [2.6](/filings/0001193125-26-265857.md) | [1.7 d](/filings/0001193125-26-386569.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | [1.1 d](/filings/0001193125-25-314318.md) | [1.1 d](/filings/0001193125-26-134566.md) | [1.2](/filings/0001193125-26-265857.md) | [1.2 d](/filings/0001193125-26-386569.md) | [1.2 d](/filings/0001193125-25-314318.md) | [1.2 d](/filings/0001193125-26-134566.md) | [1.3](/filings/0001193125-26-265857.md) | [1.3 d](/filings/0001193125-26-386569.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [3.5](/filings/0001193125-26-265857.md) | [1.0 d](/filings/0001193125-26-386569.md) | [2.0 d](/filings/0001193125-25-314318.md) | [3.8 d](/filings/0001193125-26-134566.md) | [0.8](/filings/0001193125-26-265857.md) | [1.5 d](/filings/0001193125-26-386569.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-29) | Q1 FY2023 (2023-04-29) | Q2 FY2023 (2023-07-29) | Q3 FY2023 (2023-10-28) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [14.3](/filings/0000950170-23-068143.md) | [14.3](/filings/0000950170-24-070236.md) | [14.4](/filings/0000950170-24-103118.md) | [14.4](/filings/0000950170-24-135426.md) | [14.4](/filings/0000950170-25-084826.md) | [15.1](/filings/0001193125-25-194952.md) | [15.5](/filings/0001193125-25-314318.md) | [15.4](/filings/0001193125-26-265857.md) | [15.3](/filings/0001193125-26-386569.md) | [15.4](/filings/0001193125-25-314318.md) | [15.0](/filings/0001193125-26-265857.md) | [15.1](/filings/0001193125-26-386569.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 14,862,977 at 2026-09-03, from the cover of the [10-Q filed 2026-09-09](/filings/0001193125-26-386569.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.